Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Zinc
Therapeutic Area : Dental and Oral Health
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 28, 2024
Lead Product(s) : Zinc
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Echinacea,Ascorbic Acid,Zinc
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : EZC Pak is the proven over-the-counter rapid immune support solution that contains professional strength doses of Echinacea, zinc, vitamin C (and sometimes vitamin D). It is being indicated for the reduction in illness duration for patients with upper re...
Product Name : EZC Pak
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 05, 2023
Lead Product(s) : Echinacea,Ascorbic Acid,Zinc
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc
Therapeutic Area : Dental and Oral Health
Study Phase : Phase III
Sponsor : Colgate Palmolive | Associação Latinoamericana para Promoção de Saúde Bucal e Pesquisa Odontológica
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Antibacterial Effect of a Toothpaste Containing Zinc Lactate
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
November 28, 2022
Lead Product(s) : Zinc
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase III
Sponsor : Colgate Palmolive | Associação Latinoamericana para Promoção de Saúde Bucal e Pesquisa Odontológica
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Zinc Containing Vaginal Topical " Suppository "
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 12, 2022
Lead Product(s) : Zinc
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc,Copper,Selenious Acid
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
American Regent Launches Multrys™ (trace elements injection 4*, USP)
Details : Multrys™ is indicated in neonatal and pediatric patients weighing less than 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Product Name : Multrys
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
February 09, 2021
Lead Product(s) : Zinc,Copper,Selenious Acid
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Blackmores Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
August 13, 2020
Lead Product(s) : Zinc
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Blackmores Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Two Toothpastes on Bacteria in Saliva
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 16, 2018
Lead Product(s) : Zinc
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : InClin | FGK Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 18, 2018
Lead Product(s) : Zinc
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : InClin | FGK Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 27, 2016
Lead Product(s) : Zinc
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zinc
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : London Health Sciences Centre
Deal Size : Inapplicable
Deal Type : Inapplicable
Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 30, 2014
Lead Product(s) : Zinc
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : London Health Sciences Centre
Deal Size : Inapplicable
Deal Type : Inapplicable